0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 181-200 of 497 Articles
Research Letters |  FREE
Yuting Zhang, PhD; Shang-Hua Wu, MS; A. Mark Fendrick, MD; et al.
JAMA Intern Med. 2013;173(6):468-470. doi:10.1001/jamainternmed.2013.2509.

Original Investigation |  FREE
Omid Sadr-Azodi, MD, PhD; Fredrik Mattsson, BSc; Tomas Sjöberg Bexlius, MD, PhD; et al.
JAMA Intern Med. 2013;173(6):444-449. doi:10.1001/jamainternmed.2013.2737.

Original Investigation |  FREE
Elissa R. Weitzman, ScD, MSc; Skyler Kelemen, BA; Maryanne Quinn, MD, MPH; et al.
JAMA Intern Med. 2013;173(5):345-351. doi:10.1001/jamainternmed.2013.2512.

Original Investigation |  FREE
Nicole Yvonne Nguyen, PharmD; Lisa Bero, PhD
JAMA Intern Med. 2013;173(5):338-343. doi:10.1001/jamainternmed.2013.2522.

Invited Commentary | 
Nirav Shah, MD, MPH
JAMA Intern Med. 2013;173(5):344. doi:10.1001/jamainternmed.2013.4184.

Research Letters |  FREE
Alan J. Forster, MD, MSc; Claudine Auger, PhD; for the ISTOP ADE Investigators
JAMA Intern Med. 2013;173(5):382-384. doi:10.1001/jamainternmed.2013.2002.

Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2013;173(5):384-385. doi:10.1001/jamainternmed.2013.2965.

Research Letters |  FREE
Peter Doshi, PhD; Tom Jefferson, MD
JAMA Intern Med. 2013;173(5):380-382. doi:10.1001/jamainternmed.2013.3838.
Includes: Supplemental Content

Commentary | 
Robert Steinbrook, MD
JAMA Intern Med. 2013;173(5):373-374. doi:10.1001/jamainternmed.2013.3842.

Original Investigation |  FREE
Ralph Gonzales, MD, MSPH; Tammy Anderer, PhD, CRNP; Charles E. McCulloch, PhD; et al.
JAMA Intern Med. 2013;173(4):267-273. doi:10.1001/jamainternmed.2013.1589.

Original Investigation |  FREE
Gerald Liew, PhD; Paul Mitchell, PhD; Tien Yin Wong, PhD; et al.
JAMA Intern Med. 2013;173(4):258-264. doi:10.1001/jamainternmed.2013.1583.

Invited Commentary | 
Sanjay Kaul, MD; George A. Diamond, MD
JAMA Intern Med. 2013;173(4):264-266. doi:10.1001/jamainternmed.2013.2530.

Original Investigation |  FREE
Robert Gross, MD, MSCE; Scarlett L. Bellamy, ScD; Jennifer Chapman, MPH; et al.
JAMA Intern Med. 2013;173(4):300-306. doi:10.1001/jamainternmed.2013.2152.

Invited Commentary | 
David R. Bangsberg, MD, MPH; Jessica E. Haberer, MD, MS
JAMA Intern Med. 2013;173(4):306-307. doi:10.1001/jamainternmed.2013.2858.

Invited Commentary | 
Jeffrey A. Linder, MD, MPH
JAMA Intern Med. 2013;173(4):273-275. doi:10.1001/jamainternmed.2013.1984.

Editorial | 
Mitchell H. Katz, MD
JAMA Intern Med. 2013;173(3):178. doi:10.1001/jamainternmed.2013.1838.

Editor's Correspondence | 
Bruno Michel, PharmD, PhD; Bapiste Quelennec, PharmD; Emmanuel Andres, MD, PhD
JAMA Intern Med. 2013;173(3):246-247. doi:10.1001/jamainternmed.2013.1235.

Editor's Correspondence | 
Mónica Tarapués, MD; Gloria Cereza, MD; Albert Figueras, MD
JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.1614.

Editor's Correspondence | 
Beatrice A. Golomb, MD, PhD; Sabrina Koperski, BS
JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.2113.

Original Investigation |  FREE
Aaron S. Kesselheim, MD, JD, MPH; Alexander S. Misono, MD, MBA; William H. Shrank, MD, MSHS; et al.
JAMA Intern Med. 2013;173(3):202-208. doi:10.1001/2013.jamainternmed.997.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA
Viewpoint  | 
Educational Opportunities With Postevent Debriefing
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.